公开(公告)号：EP1323423A1

公开(公告)日：2003-07-02

申请号：EP03075776.9

申请日：2000-04-04

申请人： Pharmacia Italia S.p.A.

发明人： Geroni, Maria Cristina ,  Ripamonti, Marina ,  Caruso, Michele ,  Suarato, Antonio

IPC分类号： A61K31/70 ,  A61K31/675

CPC分类号： A61K45/06 ,  A61K31/675 ,  A61K31/70 ,  A61K2300/00

摘要： The present invention relates to combined preparations comprising a morpholinyl anthracycline administered in combination anticancer agents chosen from an alkylating agent, an antimetabolite, a topoisomerase II inhibitor, a topoisomerase I inhibitor and an antimitotic drug, which are useful anticancer therapy, particularly in the treatment of a primary or metastatic liver cancer.

摘要翻译： 本发明涉及包含作为有用的抗癌治疗的选自烷化剂，抗代谢物，拓扑异构酶II抑制剂，拓扑异构酶I抑制剂和抗有丝分裂药物的组合抗癌剂中的吗啉基蒽环霉素的组合制剂，特别是在治疗 原发性或转移性肝癌。